Icatibant Injection
Product Images NDC 62332-654
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 62332-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Icatibant-fig-b (Icatibant Fig B)
Icatibant-fig-c (Icatibant Fig C)
Icatibant-fig-d (Icatibant Fig D)
Icatibant-fig-e (Icatibant Fig E)
Icatibant-fig-f (Icatibant Fig F)
Icatibant-fig-g (Icatibant Fig G)
Icatibant-fig-h (Icatibant Fig H)
Icatibant-fig-i (Icatibant Fig I)
Icatibant-fig-j (Icatibant Fig J)
Icatibant-fig-k (Icatibant Fig K)
Icatibant-fig-l (Icatibant Fig L)
Icatibant-fig-m (Icatibant Fig M)
Icatibant-fig-n (Icatibant Fig N)
Icatibant-fig-o (Icatibant Fig O)
Icatibant-graph (Icatibant Graph)
This text provides information on the proportion of patients not achieving a 50% reduction in symptoms after receiving Ieatibant Injection compared to a placebo. The data is based on a study with 43 patients in the Ieatibant group and 45 patients in the placebo group. The information is presented in a chart format, showing the time from the dose in hours.*
Icatibant-monocarton (Icatibant Monocarton)
This text provides information about Icatibant Injection produced by Alembic Pharmaceuticals. The medication comes in a 30 mg/3 mL prefilled syringe for subcutaneous use only. It is essential to store the injection between 2-25°C (3 to 77°F) and not freeze it. The syringe is designed for single-use and comes with a protective cap. The packaging includes instructions for use, dosing, and administration. Inactive ingredients in the injection include sodium chloride, glacial acetic acid, sodium hyaluronate, and water for injection. It is important to refer to the package insert for complete prescribing information.*
Icatibant-outercarton (Icatibant Outercarton)
This text appears to be a detailed description of a pharmaceutical product, specifically Icatibant Injection in prefilled syringes. It provides information on the active ingredient, dosage, administration instructions, storage conditions, contact details, and warnings. The product is indicated for subcutaneous use only. The text emphasizes the necessity to follow the package insert for prescribing information, dosage, and administration. Additionally, it mentions the presence of preservatives and the need to discard any unused portion. Overall, it serves as a comprehensive guide for healthcare professionals and patients regarding the proper use of the medication.*
Icatibant-pfs-label (Icatibant Pfs Label)
Icatibant-structure (Icatibant Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.